International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

New Corporate Member

new corporate member anaptysbio

The International Psoriasis Council is pleased to welcome AnaptysBio as a 2022 Bronze Level Corporate Member. AnaptysBio, based in San Diego, California, is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates for patients. They are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. “We are extremely pleased to welcome AnaptysBio to the IPC family and look forward to working with them to improve the care of people with psoriasis worldwide through education, research, and advocacy,” said IPC CEO Christy Langan.

Learn more about AnaptysBio.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Categories

Recent Posts

PASI 90 blog post with Dr. Maskin

Access to Biologics in Argentina: Rethinking Time to PASI 90

Blog Post - Psoriasis Hub

IPC Partners with Scientific Education Support to Create New Psoriasis and Psoriatic Arthritis Hub

Blog -Expert Insights-Erica-Alba (1)

Monkeypox Symptoms, Treatment, Prevention, and Impact on Psoriasis Patients

Also Read

councilors

Meet Our Newest Councilors

IPC is pleased to introduce and welcome our five newest Councilors for 2022: Pravit Asawanonda, Sunil Dogra, Benjamin Ehst, Filip Rob, and Tsen-Fang Tsai. These individuals were confirmed by the IPC Board of Directors during the European Academy of Dermatology and Venereology (EADV) Congress in September.

Read More
World Psoriasis Day 2022 Graphic
mental health

2022 World Psoriasis Day

The IPC is a proud supporter of World Psoriasis Day by uniting for action with IFPA to advance care and change the perception of psoriatic disease. Watch the video below to hear IPC’s key opinion leaders from around the world discuss this year’s theme – psoriasis and its impact on mental health.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.